vascularsolutions
BDX owes $340m to RVP in anti-trust case | Medtech legal news for the week of November 17, 2014
Feds indict Vascular Solutions, CEO over Vari-Lase
CryoVascular founder looks to get PolarCath back on the market
Vascular Solutions, Boston Scientific settle catheter patent spat
DOJ declares $520k victory as Vascular Solutions refutes allegations
Vascular Solutions (NSDQ:VASC) issued a special statement this week after the U.S. Justice announced that it had won a $520,000 settlement after accusing the company of selling a medical device without proper FDA approval.
Vascular Solutions issues Class I recall for pressure-sensing catheters
C.R. Bard posted major profit growth in its 1st quarter | Medtech Wall Street news for the week of Apr. 28, 2014
Vascular Solutions lowers 2014 forecast on higher legal fees
Vascular Solutions (NSDQ:VASC) wasn’t making friends on Wall Street this week after the company missed expectations for Q1 and lowered its forecast for the rest of the year.
TAVI: Court limits U.S. sales of Medtronic’s CoreValve | Medtech legal news for the week of Apr. 21, 2014
Appeals court vacates ban on Boston Scientific’s Guidezilla catheter
